Repozytorium
Wyszukaj
Kolekcje
Inne
Photoactive liposomal formulation of PVP-conjugated chlorin e6 for photodynamic reduction of atherosclerotic plaque.
Autorzy
Rok wydania
2019
Czasopismo
International Journal of Molecular Sciences
Numer woluminu
20
Strony
3852/1-3852/15
DOI
10.3390/ijms20163852
Kolekcja
Język
Angielski
Typ publikacji
Artykuł
Streszczenie
Background: Liposomes serve as delivery systems for biologically active compounds. Existing technologies inefficiently encapsulate large hydrophilic macromolecules, such as PVP-conjugated chlorin e6 (Photolon). This photoactive drug has been widely tested for therapeutic applications, including photodynamic reduction of atherosclerotic plaque. Methods: A novel formulation of Photolon was produced using “gel hydration technology”. Its pharmacokinetics was tested in Sus scrofa f. domestica. Its cellular uptake, cytotoxicity, and ability to induce a phototoxic reaction were demonstrated in J774A.1, RAW264.7 macrophages, and vascular smooth muscle (T/G HA-VSMC) as well as in vascular endothelial (HUVEC) cells. Results: Developed liposomes had an average diameter of 124.7 ± 0.6 nm (polydispersity index (PDI) = 0.055) and contained >80% of Photolon). The half-life of formulation in S. scrofa was 20 min with area under the curve (AUC) equal to 14.7. The formulation was noncytotoxic in vitro and was rapidly (10 min) and efficiently accumulated by macrophages, but not T/G HA-VSMC or HUVEC. The accumulated quantity of photosensitizer was sufficient for induction of phototoxicity in J774A.1, but not in T/G HA-VSMC. Conclusions: Due to the excellent physical and pharmacokinetic properties and selectivity for macrophages, the novel liposomal formulation of Photolon is a promising therapeutic candidate for use in arteriosclerosis treatment when targeting macrophages but not accompanying vascular tissue is critical for effective and safe therapy.
Słowa kluczowe
liposomes, Photolon, photodynamic therapy, arteriosclerosis, macrophages, pharmacokinetics, vascular smooth muscle cells, vascular endothelial cells
Licencja otwartego dostępu
Licencja na prawach której można swobodnie kopiować, rozprowadzać, zmieniać i remiksować objęty prawem autorskim utwór (Utwór-przedmiot prawa autorskiego) pod warunkiem podania imienia i nazwiska autora utworu pierwotnego oraz źródła pochodzenia utworu.
Pełny tekst licencji: https://creativecommons.org/licenses/by/3.0/pl/legalcode
Adres publiczny
http://dx.doi.org/10.3390/ijms20163852
Strona internetowa wydawcy
Podobne publikacje
Therapeutic Potential of a Water-Soluble Silver-Diclofenac Coordination Polymer on 3D Pancreatic Cancer Spheroids
Jaros Sabina W., Komarnicka Urszula K., Kyzioł Agnieszka, Pucelik Barbara, Nesterov Dmytro S., Kirillov Alexander M., Smoleński Piotr
Two-photon absorption and the design of two-photon dyes.
Pawlicki Miłosz, Collins H. A., Denning R. G., Anderson Harry L.
The new sensitizing agents for photodynamic therapy: 21-selenaporphyrin and 21-thiaporphyrin.
Marcinkowska E., Ziółkowski Piotr, Pacholska Ewa, Latos-Grażyński Lechosław, Chmielewski Piotr J., Radzikowski Czesław